Literature DB >> 16203681

14-3-3 proteins: regulators of numerous eukaryotic proteins.

G Paul H van Heusden1.   

Abstract

14-3-3 proteins form a family of highly conserved proteins capable of binding to more than 200 different mostly phosphorylated proteins. They are present in all eukaryotic organisms investigated, often in multiple isoforms, up to 13 in some plants. 14-3-3 binding partners are involved in almost every cellular process and 14-3-3 proteins play a key role in these processes. 14-3-3 proteins interact with products encoded by oncogenes, with filament forming proteins involved in Alzheimer'ss disease and many other proteins related to human diseases. Disturbance of the interactions with 14-3-3 proteins may lead to diseases like cancer and the neurological Miller-Dieker disease. The molecular consequences of 14-3-3 binding are diverse and only partly understood. Binding of a protein to a 14-3-3 protein may result in stabilization of the active or inactive phosphorylated form of the protein, to a conformational alteration leading to activation or inhibition, to a different subcellular localization or to the interaction with other proteins. Currently genome- and proteome-wide studies are contributing to a wider knowledge of this important family of proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203681     DOI: 10.1080/15216540500252666

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  48 in total

1.  Structural basis for protein-protein interactions in the 14-3-3 protein family.

Authors:  Xiaowen Yang; Wen Hwa Lee; Frank Sobott; Evangelos Papagrigoriou; Carol V Robinson; J Günter Grossmann; Michael Sundström; Declan A Doyle; Jonathan M Elkins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

2.  Molecular basis of the 14-3-3 protein-dependent activation of yeast neutral trehalase Nth1.

Authors:  Miroslava Alblova; Aneta Smidova; Vojtech Docekal; Jan Vesely; Petr Herman; Veronika Obsilova; Tomas Obsil
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

3.  A comprehensive analysis of the 14-3-3 interactome in barley leaves using a complementary proteomics and two-hybrid approach.

Authors:  Peter J Schoonheim; Helena Veiga; Daniel da Costa Pereira; Giulia Friso; Klaas J van Wijk; Albertus H de Boer
Journal:  Plant Physiol       Date:  2006-12-15       Impact factor: 8.340

4.  Dimerization is essential for 14-3-3zeta stability and function in vivo.

Authors:  Georgia Messaritou; Sofia Grammenoudi; Efthimios M C Skoulakis
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  Transcriptome-wide identification and stress properties of the 14-3-3 gene family in cotton (Gossypium hirsutum L.).

Authors:  Guiling Sun; Fuliang Xie; Baohong Zhang
Journal:  Funct Integr Genomics       Date:  2011-07-31       Impact factor: 3.410

Review 6.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

7.  Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.

Authors:  Sumit J Shah; Kenneth H Yu; Vineet Sangar; Samuel I Parry; Ian A Blair
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

8.  14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.

Authors:  Siwei Tang; Chen Bai; Pengyuan Yang; Xian Chen
Journal:  J Proteome Res       Date:  2013-05-09       Impact factor: 4.466

9.  Extraction and identification of membrane proteins from black widow spider eggs.

Authors:  Si-Ling Fu; Jiang-Lin Li; Jia Chen; Qiu-Ting Wang; Jian-Jun Li; Xian-Chun Wang
Journal:  Dongwuxue Yanjiu       Date:  2015-07-18

10.  Presence and distribution of 14-3-3 proteins in human ocular surface tissues.

Authors:  Jwalitha Shankardas; Michelle Senchyna; Slobodan D Dimitrijevich
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.